Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women

Obstetrics and Gynecology

Volumn 111, Issue 6, 2008, Pages 1380-1387

  Denny, Lynette ^a,b   Boa, Rosalind ^c   Williamson, Anna Lise ^c   Allan, Bruce ^c   Hardie, Diane ^c   Stan, Ress ^c   Myer, Landon ^c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COLPOSCOPY; CYTOLOGY; DISEASE COURSE; DNA DETERMINATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN TISSUE; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SOUTH AFRICA; SQUAMOUS CELL; SQUAMOUS EPITHELIUM; UTERINE CERVIX DISEASE; VIRUS ENTRY; VIRUS INFECTION; VIRUS LOAD; VIRUS TYPING; WART VIRUS; ADOLESCENT; COMPARATIVE STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; PATHOLOGY;

ADOLESCENT; ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; VIRAL LOAD;

EID: 47749135917     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181743327     Document Type: Article

References (17)

1. Joint United Nations Programme on AIDS/HIV. 2006 report on global AIDS epidemic. Available at: http://www.unaids. org/en/KnowledgeCentre/HIVData/ GlobalReport/default.asp. Retrieved March 26, 2008. p. 11.
2. Ferlay BF, Pisani P, Parkin DM. Globocan 2002. cancer incidence, mortality and prevalence worldwide. IARC cancer base No. 5 version 2.0. Lyon (France): IARC Press; 2004.
3. Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC Jr. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997;337:1343-9.
4. Palefsky JM, Minkoff H, Kalish LA, Levine, Sacks HS, Garcia P, et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999;91:226-36.
5. Ellerbrock TV, Chiasson MA, Bush TJ, Sun XW, Sawo D, Brudney, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000;283:1031-7.
6. Harris TG, Burk RD, Palefsky JM, Massad LS, Bang JY, Anastos K, et al. Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results. JAMA 2005;293:1471-6.
7. Clifford GM, PoleselJ, Rickenbach M, Dal Maso L, Keiser O, Kofler A, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005;97:425-32.
8. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000;92:1500-10.
9. Clifford GM, Gonçalves MA, Franceschi S, HPV and HIV Study Group. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS 2006;20:2337-2344.
10. Kitchener H, Nelson L, AdamsJ, Mesher D, Sasieni P, Cubie H, et al. Colposcopy is not necessary to assess the risk to the cervix in HIV-positive women: an international cohort study of cervical pathology in HIV-1 positive women. IntJ Cancer 2007;121:2484-91.
11. Huber PJ. The behavior of maximum likelihood estimates under nonstandard conditions. In: LeCam LM, Newman J, eds. Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability; December 27, 1965 to January 7, 1966, Berkeley, California. Vol 1. Berkeley (CA): University of California Press; 1967. p. 221-3.
12. White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica 1980;48:817-38.
13. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine 2006;24:S11-25.
14. Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Shepherd BE, Hicks ML, Stringer EM, et al. Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol 2006;103:1017-22.
15. Hawes SE, Critchlow CW, Faye Niang MA, Diouf MB, Diop A, Touré P, et al. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections. J Infect Dis 2003;188:555-63.
16. La Ruche G, You B, Mensah-Ado I, Bergeron C, Montcho C, Ramon R, et al. Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women. IntJ Cancer 1998; 76:480-6.
17. + T-cell exhaustion in typical progressors but not in long-term progressors. Blood 2007:109:4671-8.